Demand for insulin increased in pharmacies
[ad_1]
In pharmacies in Russia, the demand for insulin drugs increased again in autumn, RBC reports citing data from the marketing agency DSM Group.
Sales of insulin preparations in September amounted to 97.7 thousand packs, which is 15% more than was sold in August.
The network aggregator Megapteka, which unites 25,000 pharmacy outlets in 78 Russian regions, reported that in September-October, sales of all insulins in packages increased by almost 2.5 times compared to the same period in 2021.
Most of all, the increased demand affected analogue, the most expensive insulins, the agency notes, for some of them it increased by 8, 11 and even 17 times.
Experts believe that the increased demand will not lead to a shortage, since insulin supplies will last for 9 months.
DSM Group CEO Sergey Shulyak believes that sales growth may indicate problems with the issuance of insulin on preferential prescriptions due to disruption in supplies under government tenders. The reason for this may be low initial maximum contract prices, which are formed taking into account last year’s auctions and the maximum registered prices for generics.
Another RBC expert agrees that the reason for the shortage of insulin can hardly be called logistical difficulties and the geopolitical situation.
The Headway Company, which monitors public procurement in the pharmaceutical industry, calculated that tenders for insulin for 9 months of 2022 were canceled by 5.9 billion rubles. A year earlier, this figure was 3.2 billion rubles.
[ad_2]
Source link
